---
document_datetime: 2023-09-21 21:42:32
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.0989851
conversion_datetime: 2025-12-23 06:07:07.47071
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Yargesa

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                     |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0012              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 17/02/2023                          |                                             | SmPC and PL                      | To update section 4.4, 4.6 and 5.3 in order to improve clarity following assessment of same changes for reference product Zavesca (EMEA/H/C/000435/II/0072/G). Package leaflet has been update accordingly. |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0013   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                 | 27/01/2023   | n/a        |                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|
| R/0011    | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 11/11/2021   | 11/01/2022 | SmPC, Annex II and PL |
| IB/0010   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                    | 27/01/2020   | 29/01/2021 | SmPC                  |
| IA/0009   | B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size                                                                                                 | 12/08/2019   | n/a        |                       |
| IB/0007   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 20/03/2019   | 15/04/2019 | SmPC and PL           |
| IAIN/0006 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                       | 15/03/2019   | 15/04/2019 | Annex II and PL       |

<div style=\"page-break-after: always\"></div>

| IB/0008   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate   | 12/03/2019   | n/a        |                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| T/0005    | Transfer of Marketing Authorisation                                                                                                                                                                            | 11/12/2018   | 12/02/2019 | SmPC, Labelling and PL |
| II/0004   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                    | 04/10/2018   | n/a        |                        |
| IA/0003   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                     | 27/04/2018   | n/a        |                        |
| IA/0002   | B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                                      | 19/02/2018   | n/a        |                        |
| IB/0001   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                      | 10/05/2017   | 19/04/2018 | SmPC                   |